Chimerix Investor Relations Material

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company is committed to developing antiviral medications for the treatment of viral infections that have no viable alternatives and filing for approval of these products with regulatory agencies in the United States and abroad. The Company focuses on antiviral and antibacterial agents. It discovers, develops, acquires and commercializes products through internal research with a long-term strategic view that drives growth of its portfolio of medicines for unmet medical needs.